AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist

0.067
-0.003-4.29%

20min DelayNot Open Nov 26 15:40 AET

5.04MMarket Cap-3045P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

Cost of revenue

Gross profit

Operating expense

-62.71%3.35M

111.69%8.98M

73.65%4.24M

-28.33%2.44M

3.41M

Selling and administrative expenses

-33.17%859.63K

42.86%1.29M

-9.36%900.39K

-28.58%993.39K

--1.39M

-General and administrative expense

-33.17%859.63K

42.86%1.29M

-9.36%900.39K

-28.58%993.39K

--1.39M

Research and development costs

-72.45%2.04M

149.80%7.4M

160.05%2.96M

-12.38%1.14M

--1.3M

Other operating expenses

53.67%449.55K

-22.75%292.53K

22.13%378.7K

-56.74%310.08K

--716.85K

Operating profit

62.71%-3.35M

-111.69%-8.98M

-73.65%-4.24M

28.33%-2.44M

-3.41M

Net non-operating interest income (expenses)

-38.30%491.82K

897.84%797.08K

-49.69%79.88K

-4.17%158.79K

165.7K

Non-operating interest income

-38.30%491.82K

897.84%797.08K

-49.69%79.88K

-4.17%158.79K

--165.7K

Other net income (expenses)

180.87%1.21M

107.20%432.35K

208.66K

-117.95K

Special income (charges)

----

---117.95K

-Less:Impairment of capital assets

----

--117.95K

Other non-operating income (expenses)

180.87%1.21M

107.20%432.35K

--208.66K

----

Income before tax

78.81%-1.64M

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Income tax

Earnings from equity interest net of tax

Net income

78.81%-1.64M

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Net income continuous operations

78.81%-1.64M

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

---3.36M

Noncontrolling interests

Net income attributable to the company

78.81%-1.64M

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

78.81%-1.64M

-96.04%-7.75M

-73.09%-3.95M

32.03%-2.28M

-3.36M

Diluted earnings per share

78.86%-0.0218

-96.01%-0.1031

-73.03%-0.0526

49.16%-0.0304

-0.0598

Basic earnings per share

78.86%-0.0218

-96.01%-0.1031

-73.03%-0.0526

49.16%-0.0304

-0.0598

Dividend per share

0.1863

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue
Cost of revenue
Gross profit
Operating expense	-62.71%3.35M	111.69%8.98M	73.65%4.24M	-28.33%2.44M	3.41M
Selling and administrative expenses	-33.17%859.63K	42.86%1.29M	-9.36%900.39K	-28.58%993.39K	--1.39M
-General and administrative expense	-33.17%859.63K	42.86%1.29M	-9.36%900.39K	-28.58%993.39K	--1.39M
Research and development costs	-72.45%2.04M	149.80%7.4M	160.05%2.96M	-12.38%1.14M	--1.3M
Other operating expenses	53.67%449.55K	-22.75%292.53K	22.13%378.7K	-56.74%310.08K	--716.85K
Operating profit	62.71%-3.35M	-111.69%-8.98M	-73.65%-4.24M	28.33%-2.44M	-3.41M
Net non-operating interest income (expenses)	-38.30%491.82K	897.84%797.08K	-49.69%79.88K	-4.17%158.79K	165.7K
Non-operating interest income	-38.30%491.82K	897.84%797.08K	-49.69%79.88K	-4.17%158.79K	--165.7K
Other net income (expenses)	180.87%1.21M	107.20%432.35K	208.66K		-117.95K
Special income (charges)	----	----	----	----	---117.95K
-Less:Impairment of capital assets	----	----	----	----	--117.95K
Other non-operating income (expenses)	180.87%1.21M	107.20%432.35K	--208.66K	----	----
Income before tax	78.81%-1.64M	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	78.81%-1.64M	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Net income continuous operations	78.81%-1.64M	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	---3.36M
Noncontrolling interests
Net income attributable to the company	78.81%-1.64M	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	78.81%-1.64M	-96.04%-7.75M	-73.09%-3.95M	32.03%-2.28M	-3.36M
Diluted earnings per share	78.86%-0.0218	-96.01%-0.1031	-73.03%-0.0526	49.16%-0.0304	-0.0598
Basic earnings per share	78.86%-0.0218	-96.01%-0.1031	-73.03%-0.0526	49.16%-0.0304	-0.0598
Dividend per share	0.1863
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data